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Figure 1: A sketch showing the directionality of dynein and kinesin.
If either of these two “motors” malfunctions, materials cannot be 
transported correctly and the cell cannot function correctly. Previous 
work in the lab of Dr. Stephen King at UMKC done in vitro, has shown 
that the molecule dynactin helps dynein stay on the microtubule tracks, 
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Introduction:
 All human cells transport materials from the cell surface to the 
interior of the cell by forming vesicles under the cell membrane. These 
vesicles are moved, through endosomes, to the Golgi, and they are sorted 
and processed along the way. The transport of the vesicles inside the cell 
is referred to as trafficking. There are two cellular protein complexes that 
transport vesicles along microtubules during trafficking 1) dynein, which 
transports materials from the cell surface to the Golgi and 2) kinesin, 
which moves materials from the Golgi to the periphery of the cell. 
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as dynein moves vesicles inward. In particular, the King lab has shown 
that the p150 subunit of dynactin plays an essential role in dynein-based 
trafficking.
p150 subunit of dynactin
Figure 2: If dynein (shown in green) becomes dissociated from the microtubule, dynactin 
(in blue) acts as a tether to make dynein more processive. For more detail, see Figure 11 in 
the Supplemental Images
Based on the in vitro experiments there would be a significant 
decrease in the distance in the cells that have mutant p150, compared to 
the WT cells.(see Figure 3) 
Figure 3: Dot plots showing the affect of p150 mutations in vitro. 
Dynactin effects on bead motility
Recently, it has been shown that a variety of neurodegenerative 
diseases result from mutations in the p150 subunit of dynactin. This work 
focuses on mutations of the p150 subunit of dynactin, which we believe to 
be linked to Amyotrophic Lateral Sclerosis (ALS) and other human motor 
neuron diseases. 
Figure 4: p150 polypeptide sequence  The p150 domains discussed in the text include the 
CAP-Gly and basic microtubule binding domain (MTBDs) and two predicted coiled-coil do-
mains (CC1 and CC2). Amino acid positions of four identified human mutations are in bold, 
***   show the position of the G59S, G71R, G71E, G71A, T72P, and Q74P mutations.   
ALS or “Lou Gehrig’s Disease” is a condition that is associated with 
the degeneration of motor neurons. In humans, the motor neurons are 
responsible for the transmission of signals along nerve fibers between the 
brain and muscles. If a trafficking defect occurs in nerve cells, it could be 
particularly harmful to humans as it may result in the death of the nerve 
cell and ultimately the complete paralysis of the patient. 
For this work, cellular trafficking in live cells with the Wild Type 
p150 was compared to that of cells with the mutant p150. Distance and 
velocity of the movements was measured for both dynein and kinesin. 
The percentage of movements, that is, the number of movements/the 
total number of vesicles was also calculated. Fluorescence microscopy 
techniques were used to actually see the trafficking of the fluorescent 
cargoes and computer analysis software
 was used to characterize and quantify the amount of cellular trafficking 
between the different conditions.
Methods: 
Control experiments were conducted primarily to observe dynein/
dynactin-based vesicle movements in Wild Type (WT) MRC5 cells. Dr. 
King’s lab has selected these MRC5 cells to study because they are very 
flat, which makes it easier to observe individual fluorescent vesicles 
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moving along microtubules inside them. The cells were placed at low 
temperature (4°C) in protein-free media for five minutes. This low 
temperature is used to slow the initial step of membrane transport, and 
the protein-free media will ensure that the cells deplete the external 
supply of free proteins. This treatment enhances the cells ability to take 
up our fluorescent marker, which is attached to bovine serum albumin 
(BSA) in preparation for a ‘pulse-chase’ style experiment. Texas Red-
BODIPY-ceramide (TR-BODIPY) was used as a fluorescent marker. The 
Texas Red portion is a fluorescent moiety that is attracted to a particular 
ceramide sphingolipid. TR-BODIPY can bind to any membrane, but has a 
particularly high affinity for Golgi membranes.
While the cells were still at 4°C, the TR-BODIPY-BSA was added to 
the media for five minutes of incubation during which the BSA bound 
to cell surface receptors. The cells were then rinsed twice with protein-
free media and then placed into a specialized live cell viewing chamber 
with complete media, in preparation for a ‘pulse-chase’ type experiment. 
The cells were warmed up to 37 °C to allow the TR-BODIPY-BSA to be 
internalized by endocytosis into endosomes. In the endosomes, the BSA 
was cleaved from the TR-BODIPY and the TR-BODIPY was transported, 
in transport vesicles, to the Golgi
. Since the vesicles are spheres of membrane surrounding the material 
being trafficked, the trafficking of each of the vesicles can be seen, due to 
the bright fluorescent TR moiety. 
The next step of the project was to eliminate the WT p150 and 
introduce the mutant p150, instead of WT p150. To replace p150 levels 
in living cells, a siRNA approach was used, in which a plasmid was 
transfected into the cells (two days before imaging). This plasmid
 contained genes expressing a Blue Fluorescent Protein (BFP) from a 
CMV promoter and a small RNA against the 3’ UTR region of p150 that 
targets p150 mRNA for degradation, via standard si knockdown (see 
Figure 6). Thus the WT p150 was eliminated from the cell and we could 
identify those cells by their blue color (because of the BFP).
Figure 6: Two cells showing expression of the BFP, but with very different Golgis and per-
centage of vesicles. (A) at time 28 min., corresponds to video 1, (B) 41 min. corresponds to 
video 2. The bright spots are the vesicles.
A   B
 Figure 5: A drawing which shows the plasmid containing the BFP and the RNAi against the 
untranslated region of p150.
These movements of the fluorescent vesicles were recorded on the 
departmental High Resolution Microscope in 50-second movies of 500 
frames each. In WT cells, the trafficking was robust for up to 60 minutes. 
These movies were then analyzed using MetaMorph imaging software to 
determine the frequency of motility events and the distance and velocity 
of each individual movement. The movements can be seen as Figure 7 
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demonstrates. The program will help track the vesicles and produce a 
Kymograph (Figure 8). The Kymograph is a graph of the intensity of the 
fluorescence along the line drawn on the movie. The top of the graph 
corresponds to frame 0, time = 0 seconds, and the bottom is frame 500, 
time = 50 seconds. Thus, the distance and slope of the graph will give us 
an indication of what trafficking occurs in the cells. Once the kymograph 
(Figure 8) has been made, the actual distance in microns and the velocity 
in microns/sec. can be calculated (see Figure 9).  These calculations take 
into account the number of pixels that correspond to one micron from 
previous calibrations of the microscope with a micrometer.
Figure 9 (Bottom, Left): From the distance and angle of the line on the kymograph, 
we can account for the calibration of the microscope and calculate the distance and angle 
moved.
Figure 8: The angle of these lines is 
used to determine the velocity at which 
the vesicles moved and the length is 
used to determine the distance moved.
Figure 7: The arrows indicate the position of the vesicles at the times indicated. The blue 
arrows indicate the vesicle’s position in the previous images. A line drawn between these 
points is used to determine the area graphed. The computer tracks the movements in this 
area and the Kymograph is produced, as is shown in the screen snapshot show in Figure 3.
Results:
After the cells were transfected with the plasmid containing the RNAi 
and the BFP, I compared distance and velocity of dynein and kinesin-
based movements as well as the percentages for each. A summary of 
this analysis can be seen in Table 1. This shows that while the distance 
and velocity remained comparable, the percentage of movements was 
significantly altered. An example of this decrease in percentage of 
movements can be seen in the supporting. 
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Table 1:  A comparison of the distance and velocity for Dynein and Kinesin and the per-
centage of movements in each experiment. * = P< 001 Student’s t-test
 While the velocity of kinesin in the BFP-UTR2 cells was shown 
to be significantly different between two cell populations, the distance 
for kinesin and both the velocity and distance of dynein were quite 
similar. This indicates that while there is a visual difference between 
cells that have the RNAi and WT cells, it is not the velocity and distance 
of the movements that is changed. Thus we looked at the percentages 
of movements, that is, how many of the vesicles in a cell actually move. 
In the cells with the BFP-UTR2, there is a drastic reduction in the 
percentage of movements when compared to WT cells. 
 What was most conspicuous was the fact that some cells had 
the plasmid in them, as seen by the expression of BFP, but behaved like 
WT cells. We thus concluded that in the blue cells, some were displaying 
the mutant phenotype, while some were displaying a WT phenotype.We 
concluded that the RNAi targeting the untranslated region of p150 was 
not being consistently effective. The plasmid was clearly in the cells, but 
the RNAi did not seem to be causing a phenotype, even though it is on 
the same plasmid. We expect the RNAi was made, but the level may not 
have been high enough to remove all cellular p150 RNAs. 
Figure10: Graph showing the difference in percentage of movements between 
WT and BFP-UTR2 cells. The WT percentages are shown in red and are on the 
left y-axis. The BFP percentages are shown in blue and are on the right y-axis.
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Conclusions:
 The RNAi used did indeed affect the global function of dynein-
based transport. However, the distance and velocity of individual 
movements, when they occurred, were not affected. The affect of the 
RNAi was a decrease in the number of movements. This indicates that 
when a vesicle moves in a mutant cell, it moves similarly to a vesicle in a 
WT cell. Also, the number of vesicles was decreased in the mutant cells. 
Since p150 is only known to be involved in the binding of vesicles to 
microtubules, it is not immediately apparent if a mutation in p150 would 
affect vesicle formation or only its transport. Likewise, the decrease in 
the number of kinesin-based movements as a result of the p150 mutation 
indicates that any mutation in the cell can affect processes other than 
that with which it is directly related.
 An RNAi to a different region of p150, such as in the coding 
region, may have different results. Experiments using the same 
techniques with a new RNAi may have a more consistent effect on p150. 
If mutations in the coding region of p150 have consistent similar results 
to the blue cells with a mutant phenotype seen in these experiments, it 
may indicate that this is the best approach to take in future studies. This 
can also be examined by introducing the RNAi into live nerve cells and 
seeing if they cause similar affects to those seen in ALS patients. If this is 
the case, RNAi may also be a means of reversing ALS by eliminating the 
mutant p150 and replacing it with the WT p150.  
Supplemental Images:
Figure 11: A representation of 
the structure of dynactin. The mi-
crotubule binding domain is what 
mutations in p150 are affecting.
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